Shannon Turley

Company: Genentech Inc

Job title: Vice President - Immunology & OMNI Biomarker Discovery


Revealing the Latest Updates in the TGF-β for Immuno-Oncology Pipeline 8:30 am

Discussing the cell types that the compound has a mechanism of action on What can a TGF-β inhibitor do relative to other targeted therapies or checkpoint inhibitors? Looking to the future for TGF-β drug developmentRead more

day: Day One

Discussion Panel: Forecasting the Future Developments in Targeting TGF-β for Immuno-Oncology: Where May the Next 3-5 Years Take Us? 11:30 am

Read more

day: Day One

© Copyright 2022 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.